Eagle Pharmaceuticals
EGRX
#10862
Rank
NZ$5.75 M
Marketcap
NZ$0.44
Share price
0.00%
Change (1 day)
-91.15%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: NZ$5.75 Million

As of July 2026 Eagle Pharmaceuticals has a market cap of NZ$5.75 Million. This makes Eagle Pharmaceuticals the world's 10862th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.75 M-42.8%
2025NZ$10.06 M-20.33%
2024NZ$12.63 M-88.23%
2023NZ$0.10 B-82.08%
2022NZ$0.59 B-37.76%
2021NZ$0.96 B14.47%
2020NZ$0.84 B-30.83%
2019NZ$1.21 B45.49%
2018NZ$0.83 B-25.54%
2017NZ$1.12 B-36.68%
2016NZ$1.77 B-12.5%
2015NZ$2.02 B629.53%
2014NZ$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.108 T 19,249,509.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$534.14 B 9,275,300.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$1.895 T 32,908,569.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$353.52 B 6,138,788.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$207.81 B 3,608,644.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$188.14 B 3,267,076.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$70.61 B 1,226,138.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel